Last update 08 May 2025

Meropenem/Vaborbactam

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Carbavance, Meropenem Trihydrate/Vaborbactam, Meropenem and vaborbactam
+ [6]
Action
inhibitors
Mechanism
PBPs inhibitors(Bacterial penicillin-binding protein inhibitors), β-lactamase inhibitors(Beta Lactamase inhibitors)
Login to view timeline

Structure/Sequence

Molecular FormulaC29H41BN4O10S2
InChIKeySDJYWZHQLNEXKV-SSHSFQATSA-N
CAS Registry2031124-72-6

External Link

KEGGWikiATCDrug Bank
-Meropenem/Vaborbactam-

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Bacteremia
Liechtenstein
20 Nov 2018
Bacteremia
European Union
20 Nov 2018
Complicated intra-abdominal infection
European Union
20 Nov 2018
Complicated intra-abdominal infection
Norway
20 Nov 2018
Complicated intra-abdominal infection
Iceland
20 Nov 2018
Complicated intra-abdominal infection
Liechtenstein
20 Nov 2018
Complicated urinary tract infection
Norway
20 Nov 2018
Complicated urinary tract infection
Iceland
20 Nov 2018
Complicated urinary tract infection
European Union
20 Nov 2018
Complicated urinary tract infection
Liechtenstein
20 Nov 2018
Gram-Negative Bacterial Infections
Iceland
20 Nov 2018
Gram-Negative Bacterial Infections
Norway
20 Nov 2018
Gram-Negative Bacterial Infections
Liechtenstein
20 Nov 2018
Gram-Negative Bacterial Infections
European Union
20 Nov 2018
Hospital-acquired pneumonia
Liechtenstein
20 Nov 2018
Hospital-acquired pneumonia
Norway
20 Nov 2018
Hospital-acquired pneumonia
European Union
20 Nov 2018
Hospital-acquired pneumonia
Iceland
20 Nov 2018
Pyelonephritis
United States
29 Aug 2017
Urinary Tract Infections
United States
29 Aug 2017
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute pyelonephritisNDA/BLA
China
15 Jan 2025
Acute pyelonephritisNDA/BLA
China
15 Jan 2025
Acute pyelonephritisNDA/BLA
China
15 Jan 2025
Complicated urinary tract infectionNDA/BLA
China
15 Jan 2025
Complicated urinary tract infectionNDA/BLA
China
15 Jan 2025
Complicated urinary tract infectionNDA/BLA
China
15 Jan 2025
Bacterial InfectionsNDA/BLA--
BacteremiaPreclinical
Brazil
01 Jul 2014
BacteremiaPreclinical
Colombia
01 Jul 2014
BacteremiaPreclinical
Israel
01 Jul 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
77
(Vabomere)
dhtjcmiimf(lyqootspqv) = gwlfxvaegz tkkxsabsxm (uximojjrhs, wnlhdnlgqw - zidjhdxgyc)
-
11 Dec 2018
Best Available Therapy
(Best Available Therapy)
dhtjcmiimf(lyqootspqv) = uivxmmbulb tkkxsabsxm (uximojjrhs, oyrvuybbvb - kwsuwtrwny)
Phase 3
47
(alojhcvwrr) = adyprjsegq wljlronvyk (hsusgxzfhg )
Positive
01 Dec 2018
Best-Available Therapy
(alojhcvwrr) = myowlkyklp wljlronvyk (hsusgxzfhg )
Phase 3
550
qsmoirvekz(yurdrsyrit) = hovuwbivvq atnudcyycu (qqmjetkmdf )
Negative
27 Feb 2018
qsmoirvekz(yurdrsyrit) = ughwjokjnf atnudcyycu (qqmjetkmdf )
Phase 3
550
rbmullulto(lzoivelasf) = teculykczr xgyfexnzxd (htrdtqlrwu, whgzjqceqt - kwtvjthrub)
-
26 Oct 2017
rbmullulto(lzoivelasf) = zhoyrnrntc xgyfexnzxd (htrdtqlrwu, npmrsfkhxc - rhszqaanpf)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free